The latest research study “Herpes Simplex Virus Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global herpes simplex virus treatment market reached a value of US$ 2.32 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 3.25 Billion by 2027 exhibiting a CAGR of 5.50% during 2022-2027.
Herpes simplex virus (HSV), also commonly known as herpes, is a contagious infection that can spread through saliva, semen, and vaginal secretions and cause painful blisters or ulcers. The two most common types of HSV are HSV-1 and HSV-2, which can lead to genital infections and orofacial diseases such as cold sores. It is usually diagnosed through fluid sampling, physical examinations, and blood tests. Nowadays, individuals are widely adopting medications such as acyclovir, valacyclovir, Abreva, Blistex, docosanol, allantoin, and famciclovir, which can help relieve symptoms, reduce the frequency and severity of outbreaks, and prevent the transmission of the virus.
Request for a Free Sample Copy of This Report: https://www.imarcgroup.com/herpes-simplex-virus-treatment-market/requestsample
Herpes Simplex Virus Treatment Market Trends:
The market is primarily driven by the rising prevalence of HSV, which can also increase the risk of obtaining and transmitting human immunodeficiency virus (HIV) infection. In addition, it can lead to serious complications like encephalitis and keratitis in people with long-term or chronic illnesses such as diabetes and hypertension. Moreover, the rising outbreak of infectious diseases and increasing cases of hospital-acquired infections are augmenting the market growth. Additionally, the growing prevalence of low immunity disorders and the rising usage of unhygienic practices in various countries represent another major growth-inducing factor.
Besides this, neonatal herpes can occur when an infant is exposed to HSV in the genital tract during delivery, which can cause lasting neurologic disability or death in infants. Along with this, the increasing number of people undergoing organ transplantation is also escalating the need for HSV treatment, as bone marrow and solid-organ transplants can lead to the reactivation of HSV infection. Furthermore, the surging investments in research and development (R&D) activities for developing new antiviral medications and expanding the treatment options for orolabial and genital herpes, along with the increasing utilization of antiviral cream or ointment that can relieve burning, itching, or tingling sensations of HSV, are anticipated to propel the market growth in the coming years.
Click here to view detailed information with table of content: https://www.imarcgroup.com/herpes-simplex-virus-treatment-market
Herpes Simplex Virus Treatment Market 2022-2027 Competitive Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the one-way valve market has been studied in the report with the detailed profiles of the key players operating in the market.
Major Players Covered:
- Agenus Inc.
- Apotex Inc.
- Avet Pharmaceuticals Inc.
- Carlsbad Tech
- GlaxoSmithKline plc
- Glenmark Pharmaceuticals Limited
- Merck & Co. Inc.
- Novartis AG
- EPI Health LLC
- F. Hoffmann-La Roche Ltd
- Fresenius SE & Co. KGaA
- Sanofi S.A.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
Key Market Segmentation:
The report has segmented the market on the basis of type, drug type, route of administration, distribution channel and region.
Breakup by Type:
- Herpes Simples Virus-1 Infection
- Herpes Simplex Virus-2 Infection
- Others
Breakup by Drug Type:
- Acyclovir
- Valacyclovir
- Famciclovir
- Others
Breakup by Route of Administration:
- Oral
- Injectable
- Topical
Breakup by Distribution Channel:
- Hospital Pharmacy
- Drug Stores
- Retail Stores
- Online Pharmacy
Breakup by Geography:
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
Ask Analyst for 10% free customized report: https://www.imarcgroup.com/request?type=report&id=5257&flag=C
Note: We are updating our reports, if you want the report with the latest primary and secondary data (2023-2028) including industry trends, market size and competitive landscape, etc. click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About IMARC Group:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: [email protected]
Phone: +1-631-791-1145
Address: 134 N 4th St.
City: Brooklyn
State: NY
Country: United States